Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity

Journal of Physiology

Volumn 587, Issue 20, 2009, Pages 4949-4961

  Schenk, Simon ^a   Harber, Matthew P ^a   Shrivastava, Cara R ^a   Burant, Charles F ^a   Horowitz, Jeffrey F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL;

ADULT; ANALYTIC METHOD; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; OBESITY; OXIDATION; PRIORITY JOURNAL; SKELETAL MUSCLE; WEIGHT REDUCTION; WESTERN BLOTTING; ENERGY EXPENDITURE; FAT MASS; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LUNG GAS EXCHANGE; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; EXERCISE; FATTY ACIDS; FEMALE; HUMANS; I-KAPPA B KINASE; INSULIN RESISTANCE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; TRIGLYCERIDES; WEIGHT LOSS;

EID: 70350674920     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.175489     Document Type: Article

References (65)

1. Assali AR, Ganor A, Beigel Y, Shafer Z, Hershcovici T. Insulin resistance in obesity: body-weight or energy balance. J Endocrinol 2001, 171:293-298.
2. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005, 54:3148-3153.
3. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 2005, 54:2351-2359.
4. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 2006, 55:2277-2285.
5. Berggren JR, Boyle KE, Chapman WH, Houmard JA. Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am J Physiol Endocrinol Metab 2008, 294:E726-E732.
6. Berggren JR, Hulver MW, Dohm GL, Houmard JA. Weight loss and exercise: implications for muscle lipid metabolism and insulin action. Med Sci Sprts Exerc 2004, 36:1191-1195.
7. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987, 79:790-800.
8. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 2004, 18:1144-1146.
9. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007, 50:790-796.
10. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA, Kraegen EW. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009, 58:550-558.
11. Cartee GD, Young DA, Sleeper MD, Zierath J, Wallberg-Henriksson H, Holloszy JO. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol Endocrinol Metab 1989, 256:E494-E499.
12. Dekker MJ, Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R, Robinson LE. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 2007, 56:332-338.
13. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999, 103:253-259.
14. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001, 86:3574-3578.
15. Fielding BA, Samra JS, Ravell CL, Frayn KN. Metabolism of individual fatty acids during infusion of a triacylglycerol emulsion. Lipids 1999, 34:535-541.
16. Frayn KN. Calculation of substrate oxidation rates in vivo from gas exchange. J Appl Physiol 1983, 55:628-634.
17. Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003, 52:2191-2197.
18. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associates with activation of protein kinase C theta and alterations in the insulin signalling cascade. Diabetes 1999, 48:1270-1274.
19. Hagenfeldt L, Wahren J, Pernow B, Raf L. Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest 1972, 51:2324-2330.
20. Hancock CR, Han D-H, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 2008, 105:7815-7820.
21. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
22. Horowitz JF, Braudy RJ, Martin WH, Klein S. Endurance exercise training does not alter lipolytic or adipose tissue blood flow sensitivity to epinephrine. Am J Physiol Endocrinol Metab 1999a, 277:E325-E331.
23. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol Endocrinol Metab 1999b, 276:E278-E284.
24. Horowitz JF, Leone TC, Feng W, Kelly DP, Klein S. Effect of endurance training on lipid metabolism in women: a potential role for PPARa in the metabolic response to training. Am J Physiol Endocrinol Metab 2000, 279:E348-E355.
25. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 2003, 284:E741-E747.
26. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002, 51:2005-2011.
27. Ivy JL, Young JC, McLane JA, Fell RD, Holloszy JO. Exercise training and glucose uptake by skeletal muscle in rats. J Appl Physiol 1983, 55:1393-1396.
28. Janssen I, Fortier A, Hudson R, Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002, 25:431-438.
29. Kanaley JA, Cryer PE, Jensen MD. Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energy-restricted diet. J Clin Invest 1993, 92:255-261.
30. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000, 279:E1039-E1044.
31. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004, 350:2549-2557.
32. Klein S, Luu K, Gasic S, Green A. Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. Am J Physiol Endocrinol Metab 1996, 270:E739-E745.
33. Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, Dohm GL, Yan Z, Newgard CB, Muoio DM. Peroxisome proliferator-activated receptor-γ co-activator 1α-mediated metabolic remodelling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 2005, 280:33588-33598.
34. Lofgren P, Hoffstedt J, Ryden M, Thorne A, Holm C, Wahrenberg H, Arner P. Major gender differences in the lipolytic capacity of abdominal subcutaneaous fat cells in obesity observed before and after long-term weight reduction. J Clin Endocrinol Metab 2002, 87:764-771.
35. Matzinger O, Schneiter P, Tappy L. Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects. Am J Physiol Endocrinol Metab 2002, 282:E125-E131.
36. Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effects of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol Endocrinol Metab 1988, 254:E248-E259.
37. Mikines KJ, Sonne B, Tronier B, Galbo H. Effects of acute exercise and detraining on insulin action in trained men. J Appl Physiol 1989, 66:704-711.
38. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?. Diabetes 2003, 52:1641-1648.
39. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, Klaus KA, Guo Z-K, Sreekumar R, Irving BA. Asian indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008, 57:1166-1175.
40. Nguyen MTA, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi N-W, Olefsky JM. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005, 280:35361-35371.
41. Ostergard T, Andersen JL, Nyholm B, Lund S, Nair KS, Saltin B, Schmitz O. Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006, 290:E998-E1005.
42. Patterson BW, Zhao G, Klein S. Improved accuracy of stable isotope tracer:tracee ratio measurements by gas chromotography/mass spectrometry. Metabolism 1998, 47:706-712.
43. Perseghin G, Price TB, Petersen KF, Roden M, Cline GW, Gerow K, Rothman DL, Shulman GI. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996, 335:1357-1362.
44. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
45. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhausl W, Shulman GI. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000, 49:701-707.
46. Ropelle ER, Pauli JR, Prada PO, de Souza CT, Picardi PK, Faria MC, Cintra DE, Fernandes MFdA, Flores MB, Velloso LA, Saad MJA, Carvalheira JBC. Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation. J Physiol 2006, 577:997-1007.
47. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000, 133:92-103.
48. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004, 12:789-798.
49. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 1994, 43:1114-1121.
50. Santomauro A, Boden G, Silva M, Rocha D, Santos R, Ursich M, Strassmann P, Wajchenberg B. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999, 48:1836-1841.
51. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007, 87:507-520.
52. Schenk S, Cook JN, Kaufman AE, Horowitz JF. Postexercise insulin sensitivity is not impaired after an overnight lipid infusion. Am J Physiol Endocrinol Metab 2005, 288:E519-E525.
53. Schenk S, Horowitz JF. Co-immunoprecipitation of FAT/CD36 and CPT-I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. Am J Physiol Endocrinol Metab 2006, 291:E254-E260.
54. Schenk S, Horowitz JF. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 2007, 117:1679-1689.
55. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118:2992-3002.
56. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol Endocrinol Metab 1995, 269:E649-E656.
57. Sinha S, Perdomo G, Brown NF, O'Doherty RM. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB. J Biol Chem 2004, 279:41294-41301.
58. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, Defronzo RA, Mandarino LJ, Musi N. Reduced skeletal muscle inhibitor of κbβ content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006, 55:760-767.
59. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 1959, 82:420-430.
60. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, Dohm GL. Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endocrinol Metab 2004, 287:E1076-E1081.
61. Toledo FGS, Menshikova EV, Azuma K, Radikova Z, Kelley CA, Ritov VB, Kelley DE. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss, despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 2008, 57:987-994.
62. Toledo FGS, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 2007, 56:2142-2147.
63. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007, 56:2085-2092.
64. Vazquez JA, Kazi U. Lipolysis and gluconeogenesis from glycerol during weight reduction with very-low-calorie diets. Metabolism 1994, 43:1293-1299.
65. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis 1992, Wiley-Liss, New York